pI: 9.625 |
Length (AA): 301 |
MW (Da): 33082 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 257 | 2d0b (A) | 56 | 303 | 20.00 | 0 | 1 | 1.05 | -0.08 |
46 | 259 | 1io2 (A) | 3 | 207 | 36.00 | 0 | 1 | 1.17 | -0.98 |
46 | 257 | 1io2 (A) | 3 | 205 | 40.00 | 0 | 1 | 1.18 | -0.81 |
42 | 268 | 3kio (A) | 26 | 257 | 45.00 | 0 | 1 | 1.27675 | -0.5 |
46 | 250 | 3p56 (D) | 30 | 238 | 47.00 | 0 | 1 | 0.956063 | 0.62 |
46 | 253 | 1uax (A) | 3 | 201 | 37.00 | 0 | 1 | 1.10423 | -0.61 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_126908)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G25100 | ribonuclease H2 subunit A |
Babesia bovis | BBOV_I000890 | ribonuclease H, putative |
Brugia malayi | Bm1_42230 | ribonuclease HI large subunit |
Candida albicans | CaO19.13915 | likely Ribonuclease HII similar to S. pombe SPAC4G9.02 and to S. cerevisiae RNH35 (YNL072W) |
Candida albicans | CaO19.6562 | likely Ribonuclease HII similar to S. pombe SPAC4G9.02 and to S. cerevisiae RNH35 (YNL072W) |
Candida albicans | CaO19_6562 | hypothetical protein |
Caenorhabditis elegans | CELE_T13H5.7 | Protein RNH-2 |
Cryptosporidium hominis | Chro.40245 | similar to ribonuclease HI large subunit (RNase HI large subunit) |
Cryptosporidium parvum | cgd4_2160 | conserved hypothetical protein |
Chlamydia trachomatis | CT_029 | ribonuclease HII |
Dictyostelium discoideum | DDB_G0277705 | hypothetical protein |
Dictyostelium discoideum | DDB_G0292584 | RNase H2 subunit A |
Drosophila melanogaster | Dmel_CG13690 | CG13690 gene product from transcript CG13690-RA |
Escherichia coli | b0183 | ribonuclease HII, degrades RNA of DNA-RNA hybrids |
Echinococcus granulosus | EgrG_000899800 | ribonuclease hi large subunit |
Entamoeba histolytica | EHI_134360 | ribonuclease H2 subunit A, putative |
Entamoeba histolytica | EHI_084700 | RNase HI large subunit, putative |
Echinococcus multilocularis | EmuJ_000899800 | ribonuclease hi large subunit |
Giardia lamblia | GL50803_6483 | Ribonuclease HI, large sub |
Homo sapiens | ENSG00000104889 | ribonuclease H2, subunit A |
Leishmania braziliensis | LbrM.13.0050 | ribonuclease HII, putative |
Leishmania braziliensis | LbrM.35.0760 | ribonuclease H, putative |
Leishmania donovani | LdBPK_130050.1 | ribonuclease HII, putative |
Leishmania donovani | LdBPK_360700.1 | ribonuclease H, putative |
Leishmania infantum | LinJ.36.0700 | ribonuclease H, putative |
Leishmania infantum | LinJ.13.0050 | ribonuclease HII, putative |
Leishmania major | LmjF.13.0050 | ribonuclease HII, putative |
Leishmania major | LmjF.36.0640 | ribonuclease H, putative |
Leishmania mexicana | LmxM.13.0050 | ribonuclease HII, putative |
Leishmania mexicana | LmxM.36.0640 | ribonuclease H, putative |
Loa Loa (eye worm) | LOAG_01088 | ribonuclease HI large subunit |
Mycobacterium leprae | ML1611c | PROBABLE RIBONUCLEASE HII PROTEIN RNHB (RNASE HII) |
Mus musculus | ENSMUSG00000052926 | ribonuclease H2, large subunit |
Mycobacterium tuberculosis | Rv2902c | Probable ribonuclease HII protein RnhB (RNase HII) |
Mycobacterium ulcerans | MUL_2054 | ribonuclease HII |
Neospora caninum | NCLIV_023470 | Ribonuclease (EC 3.1.26.-), related |
Oryza sativa | 4349811 | Os11g0153900 |
Plasmodium berghei | PBANKA_1122800 | ribonuclease H2 subunit A, putative |
Plasmodium falciparum | PF3D7_0623900 | ribonuclease H2 subunit A, putative |
Plasmodium knowlesi | PKNH_1126300 | ribonuclease H2 subunit A, putative |
Plasmodium vivax | PVX_114310 | ribonuclease H2 subunit A, putative |
Plasmodium yoelii | PY06561 | ribonuclease HII, putative |
Saccharomyces cerevisiae | YNL072W | Rnh201p |
Schistosoma japonicum | Sjp_0000830 | ko:K10743 ribonuclease H2 subunit A, putative |
Schistosoma mansoni | Smp_041890.2 | ribonuclease hi large subunit |
Schistosoma mansoni | Smp_041890.1 | ribonuclease hi large subunit |
Schmidtea mediterranea | mk4.036732.02 | |
Trypanosoma brucei gambiense | Tbg972.10.6130 | ribonuclease H, putative |
Trypanosoma brucei | Tb927.10.5070 | ribonuclease H, putative |
Trypanosoma brucei | Tb11.v5.0340 | ribonuclease HII, putative |
Trypanosoma congolense | TcIL3000_10_4240 | ribonuclease H, putative |
Trypanosoma cruzi | TcCLB.510293.70 | ribonuclease H, putative |
Trypanosoma cruzi | TcCLB.508661.50 | ribonuclease H, putative |
Toxoplasma gondii | TGME49_281510 | ribonuclease H1 large subunit, putative |
Theileria parva | TP01_0041 | ribonuclease H1 large subunit, putative |
Trichomonas vaginalis | TVAG_262310 | ribonuclease hi large subunit, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0642 | ribonuclease HII |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2949 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.10.5070 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.5070 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.5070 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.5070 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0183 | Escherichia coli | non-essential | goodall |
PBANKA_1122800 | Plasmodium berghei | Slow | plasmo |
TGME49_281510 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.